Showing results (131-140 of 461) with videos related to
Sort By:
Pageof 47
Current Clinical Pharmacology|April 22, 2010
Vascular disrupting agents (VDAs) in anticancer therapyLaura G M Daenen, Jeanine M L Roodhart, Yuval Shaked, et al.Current Clinical Pharmacology|April 22, 2010
Molecular targeted therapy in prevalent tumors: learning from the past and future perspectivesOtto Metzger-Filho, Camilo Moulin, Ahmad AwadaCurrent Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep TaberneroCurrent Clinical Pharmacology|April 22, 2010
Monoclonal antibody therapy in haematological malignanciesMartine E D Chamuleau, Arjan A van de Loosdrecht, Peter C HuijgensCurrent Clinical Pharmacology|February 17, 2010
A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and patientsFenglei Huang, Yali FuCurrent Clinical Pharmacology|February 17, 2010
Intraperitoneal drug therapy: an advantageKunal Chaudhary, Shadi Haddadin, Ravi Nistala, et al.Current Clinical Pharmacology|February 17, 2010
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosisVéronique Dartois, Clifton E BarryCurrent Clinical Pharmacology|September 6, 2016
The Therapeutic Role of Lamotrigine And Topiramate In A Depressive Patient With Anxiety Symptoms And Cognitive Decline: Neurometabolic CorrelatesLutfu Hanoglu, Burak Yulug, Tansel Cakir, et al.Current Clinical Pharmacology|June 23, 2017
Effect of Heteropterys aphrodisiaca on Anxiety and Male Exposure of Female Mice with Advanced AgeDaniela M Farias, Maria S Ostetto, Rozimeri Colleti, et al.Current Clinical Pharmacology|May 11, 2017
Effect of Crocin on Antibody Titers to Heat-Shock Protein 27 in Subjects with Metabolic SyndromeMina Nosrati, Irandokht Nikbakht-Jam, Saeid Eslami, et al.Pageof 47